BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28735996)

  • 1. Effect of HLA Matching on Pediatric Renal Transplant Graft Survival in China.
    Zhao H; Lai X; Lu J; Lin Y; Wang P; Zhu L; Wu L; Xiao Z; Wang Q; Tan J
    Transplant Proc; 2017; 49(6):1291-1293. PubMed ID: 28735996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
    Halleck F; Khadzhynov D; Liefeldt L; Schrezenmeier E; Lehner L; Duerr M; Schmidt D; Bamoulid J; Lachmann N; Waiser J; Budde K; Staeck O
    Nephrol Dial Transplant; 2016 Dec; 31(12):2143-2149. PubMed ID: 27369852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Yacoub R; Nadkarni GN; Cravedi P; He JC; Delaney VB; Kent R; Chauhan KN; Coca SG; Florman SS; Heeger PS; Murphy B; Menon MC
    Kidney Int; 2018 Feb; 93(2):482-490. PubMed ID: 28965746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
    Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
    Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
    Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation.
    Opelz G; Döhler B
    Tissue Antigens; 2013 Oct; 82(4):235-42. PubMed ID: 24461002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.
    Heidt S; Haasnoot GW; Witvliet MD; van der Linden-van Oevelen MJH; Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Otten HG; Roelen DL; Claas FHJ
    Am J Transplant; 2019 Oct; 19(10):2926-2933. PubMed ID: 31155833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study.
    Jung GO; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Kim SJ
    Transplant Proc; 2010 Apr; 42(3):766-74. PubMed ID: 20430167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.
    Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E
    Front Immunol; 2018; 9():321. PubMed ID: 29556227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA mismatch at first kidney transplant on lifetime with graft function in young recipients.
    Foster BJ; Dahhou M; Zhang X; Platt RW; Smith JM; Hanley JA
    Am J Transplant; 2014 Apr; 14(4):876-85. PubMed ID: 24612783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.